Erratum to: “Establishing New Acceptance Limits for Dissolution Performance Verification of USPC Apparatus 1 and 2 Using USPC Prednisone Tablets Reference Standard”

By DeStefano Anthony   Hauck Walter   Stippler Erika   Brown William   Li Chensheng   Huang Gloria   Jones Barbara   O’Hool Kevin   Koch William   Williams Roger  

Pharmaceutical Research, Vol. 28, Iss. 4, 2011-04 ,pp. : 938-938

Springer Publishing Company

Access to resources Recommend Favorite

Development of a Performance Verification Test for USP Apparatus 4

By Eaton Joseph   Tran Daren   Hauck Walter   Stippler Erika  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 345-351

Springer Publishing Company

Access to resources Recommend Favorite

Using the Drug Dissolution Test for the Characterization of Generics: Ofloxacin Tablets

By Dorofeev V. L.   Titov I. V.   Kochin V. Yu.   Arzamastsev A. P.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 5, 2004-05 ,pp. : 264-266

Springer Publishing Company

Access to resources Recommend Favorite

Accelerated Dissolution Testing for Controlled Release Microspheres Using the Flow-Through Dissolution Apparatus

By Collier Jarrod   Thakare Mohan   Garner Solomon   Israel Bridg'ette   Ahmed Hisham   Granade Saundra   Strong Deborah   Price James   Capomacchia A. C.  

Pharmaceutical Development and Technology, Vol. 14, Iss. 1, 2009-01 ,pp. : 9-17

Informa Healthcare

Access to resources Recommend Favorite

Olanzapine: Weight gain with standard oral tablets and weight loss following switch to orally disintegrating tablets: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1253, 2009-01 ,pp. : 30-31

Adis International

Access to resources Recommend Favorite